CG ONCOLOGY
CG Oncology formerly known as Cold Genesys is a privately-held, clinical-stage biopharmaceutical company focused on the research, acquisition, and development of novel immunotherapies. It specializes in the development of oncolytic immunotherapies to combat cancer, providing patients with new and impactful therapies. CG Oncology acquired the rights to develop CG0070 from BioSante Pharmaceuticals (Nasdaq: BPAX). A phase I/IIa dose-escalating clinical trial has already completed in 35 patients with NMIBC. Cold Genesys is hopeful to get this therapy back into the clinical setting with the initiation of the proposed phase II/III trial.
CG ONCOLOGY
Industry:
Biotechnology Health Care Health Diagnostics
Founded:
2010-01-01
Address:
Irvine, California, United States
Country:
United States
Website Url:
http://www.cgoncology.com
Total Employee:
11+
Status:
Active
Contact:
949-200-7680
Email Addresses:
[email protected]
Total Funding:
92.57 M USD
Technology used in webpage:
Google Apps For Business Google Maps Google Maps API Namecheap DNS
Similar Organizations
Aimmune Therapeutics
Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.
Audeo Oncology Inc
Audeo Oncology, Inc. is a late-stage biopharmaceutical company primarily focused on utilizing Hyaluronic Acid Chemotransport Technology.
Calidi Biotherapeutics
Calidi Biotherapeutics is a clinical-stage biotechnology company at the forefront of oncolytic virus-based immunotherapies for cancer.
Cellular Biomedicine Group
CBMG is a clinical-stage biopharmaceutical firm engaged in the development of immunotherapies for cancers and stem cell therapies.
Edgewise Therapeutics
Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.
Gritstone Bio
Gritstone Oncology is a clinical-stage biotech company that develops tumor-specific cancer immunotherapies to fight multiple cancer types.
Prothena
Prothena is a clinical-stage neuroscience company focused on the discovery and development of novel therapies.
Current Employees Featured
Founder
Investors List
ORI Capital
ORI Capital investment in Series D - CG Oncology
Camford Capital
Camford Capital investment in Series D - CG Oncology
Kissei Pharmaceutical
Kissei Pharmaceutical investment in Series D - CG Oncology
Perseverance Capital Management
Perseverance Capital Management investment in Series D - CG Oncology
ORI Capital
ORI Capital investment in Series C - CG Oncology
Perseverance Capital Management
Perseverance Capital Management investment in Series C - CG Oncology
Whitesun Healthcare Ventures
Whitesun Healthcare Ventures investment in Series B - CG Oncology
Ally Bridge Group
Ally Bridge Group investment in Series B - CG Oncology
Song Hong Fang
Song Hong Fang investment in Series B - CG Oncology
WI Harper Group
WI Harper Group investment in Series B - CG Oncology
Official Site Inspections
http://www.cgoncology.com
- Host name: 69.19.212.35.bc.googleusercontent.com
- IP address: 35.212.19.69
- Location: United States
- Latitude: 38.6583
- Longitude: -77.2481
- Timezone: America/New_York
